Navellier & Associates’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8,947
Closed -$462K 334
2021
Q1
$462K Buy
8,947
+506
+6% +$27.8K 0.08% 186
2020
Q4
$473K Buy
+8,441
New +$450K 0.09% 174

Other funds holding QGEN

Navellier & Associates's QGEN Position: Q2 2021 in Review

Navellier & Associates sold out of Qiagen (QGEN) in Q2 2021, closing a stake of 8,947 shares — an estimated $462K sold.

Navellier & Associates first reported a position in QGEN in Q4 2020 and held it in 2 quarters. The position peaked at $473K in Q4 2020. 257 funds tracked by Wall St. Rank hold QGEN as of Q2 2021.

  • Navellier & Associates reported no remaining Qiagen position as of Q2 2021 after selling out during the quarter.
  • Navellier & Associates sold 8,947 Qiagen shares in Q2 2021, an estimated $462K.
  • Navellier & Associates first reported a position in Qiagen in Q4 2020 and held it in 2 quarters.
  • Navellier & Associates's Qiagen position peaked at $473K in Q4 2020.
  • 257 funds tracked by Wall St. Rank held Qiagen as of Q2 2021.

Based on Navellier & Associates's 13F filing for Q2 2021, filed 9 Aug 2021.